SCHEMBL7477297

SCHEMBL7477297

COc1cc2c(cc1OC)/C(=C(\Nc1ccc(Cl)cc1)c1ccccc1)C(=O)N2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RET P07949 4/20 0.51
ATM Q13315 1/20 0.42
BRD4 O60885 3/20 0.41
BRD2 P25440 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EGFR P00533 1/20 0.39
KDR P35968 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
CDYL2 Q8N8U2 1/20 0.38
CDYL Q9Y232 1/20 0.38
CDY1; CDY1B Q9Y6F8 1/20 0.38
CHEK1 O14757 1/20 0.38
TLK2 Q86UE8 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5783036 1.00 RET (0.51) RETATMBRD4BRD2MEN1
SCHEMBL6330717 1.00 RET (0.51) RETATMBRD4BRD2MEN1
SCHEMBL5789112 0.92 RET (0.55) RETBRD4BRD2MEN1KMT2A
SCHEMBL5789109 0.92 RET (0.55) RETBRD4BRD2MEN1KMT2A
SCHEMBL5784002 0.90 RET (0.52) RETBRD4BRD2MEN1KMT2A
SCHEMBL5785525 0.90 RET (0.52) RETBRD4BRD2MEN1KMT2A
SCHEMBL5785496 0.90 RET (0.54) RETBRD4BRD2MEN1KMT2A
SCHEMBL5785531 0.90 RET (0.52) RETBRD4BRD2MEN1KMT2A
SCHEMBL5785488 0.90 RET (0.54) RETBRD4BRD2MEN1KMT2A
SCHEMBL6330841 0.90 RET (0.52) RETBRD4BRD2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212318-A1 SUBSTITUTED INDOLINONES AS TYROSINE KINASE INHIBITORS Boehringer Ingelheim Pharma KG (DE) 2002-06-12 EP disclosed
WO-2001016130-A1 SUBSTITUTED INDOLINONES AS TYROSINE KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-03-08 WO disclosed